Ramesh Kumar
Directeur/Bestuurslid bij OCUGEN, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Ramesh Kumar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OCUGEN, INC. | Independent Dir/Board Member | 27-09-2019 | - |
| Directeur/Bestuurslid | 27-09-2019 | - | |
| Comptroller/Controller/Auditor | - | 15-09-2023 | |
| Ocugen OpCo, Inc. | Directeur/Bestuurslid | 01-06-2019 | - |
Loopbaan van Ramesh Kumar
Eerdere bekende functies van Ramesh Kumar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRAWS PHARMA, INC. | Directeur/Bestuurslid | 29-04-2011 | 15-01-2019 |
| Algemeen Directeur | 22-12-1998 | 15-01-2019 | |
| Oprichter | 22-12-1998 | 15-01-2019 | |
| President | 22-12-1998 | 21-06-2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Hoofd Techniek/Wetenschap/O&O | - | - |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Directeur/Bestuurslid | - | - |
| Kimeragen, Inc. | Corporate Officer/Principal | - | - |
| Princeton University | Corporate Officer/Principal | - | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Opleiding van Ramesh Kumar
| University of Illinois | Doctorate Degree |
| Panjab University Chandigarh | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 10 |
| India | 2 |
Operationeel
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
| Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| OCUGEN, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| Kimeragen, Inc. | Commercial Services |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
| Ocugen OpCo, Inc. |
- Beurs
- Insiders
- Ramesh Kumar
- Ervaring
